Omega-3 for bipolar disorder: Meta-analyses of use in mania and bipolar depression

Journal of Clinical Psychiatry

Volumn 73, Issue 1, 2012, Pages 81-86

  Sarris, Jerome ^a,b   Mischoulon, David ^c   Schweitzer, Isaac ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINSEED OIL; LITHIUM; MOOD STABILIZER; OMEGA 3 FATTY ACID; PLACEBO; PSYCHOTROPIC AGENT; VALPROIC ACID;

ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; GENETIC HETEROGENEITY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84856252541     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10r06710     Document Type: Article

References (42)

1. Suppes T, Kelly DI, Perla JM. Challenges in the management of bipolar depression. J Clin Psychiatry. 2005;66(suppl 5):11-16. PubMed
2. Oswald P, Souery D, Kasper S, et al. Current issues in bipolar disorder: a critical review. Eur Neuropsychopharmacol. 2007;17(11):687-695. doi:10.1016/j.euroneuro.207.03.06 PubMed (Pubitemid 47419293)
3. Sarris J, Schoendorfer N, Kavanagh DJ. Major depressive disorder and nutritional medicine: a review of monotherapies and adjuvant treatments. Nutr Rev. 2009;67(3):125-131. doi:10.1/j.1753-487.209.0180.x PubMed
4. Sarris J, Kavanagh DJ, Byrne G. Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines. J Psychiatr Res. 2010;44(1):32-41. doi:10.1016/j.jpsychires.209.06.03 PubMed
5. Noaghiul S, Hibbeln JR. Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry. 2003;160(12): 2222-2227. doi:10.176/api.ajp.160.12.2 PubMed (Pubitemid 39619617)
6. McNamara RK, Jandacek R, Rider T, et al. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J Affect Disord. 2010;126(1-2): 303-311. doi:10.1016/j.jad.2010.03.015 PubMed
7. Hirashima F, Parow AM, Stoll AL, et al. Omega-3 fatty acid treatment and T2 whole brain relaxation times in bipolar disorder. Am J Psychiatry. 2004;161(10):1922-1924. doi:10.176/api.ajp.161.10.192 PubMed
8. Tassoni D, Kaur G, Weisinger RS, et al. The role of eicosanoids in the brain. Asia Pac J Clin Nutr. 2008;17(suppl 1):220-228. PubMed
9. Duncan RE, Bazinet RP. Brain arachidonic acid uptake and turnover: implications for signaling and bipolar disorder. Curr Opin Clin Nutr Metab Care. 2010;13(2):130-138. doi:10.1097/MCO.0b013e32836b615 PubMed
10. McNamara RK, Ostrander M, Abplanalp W, et al. Modulation of phosphoinositide-protein kinase C signal transduction by omega-3 fatty acids: implications for the pathophysiology and treatment of recurrent neuropsychiatric illness. Prostaglandins Leukot Essent Fatty Acids. 2006;75(4-5):237-257. doi:10.1016/j.plefa.206.07.09 PubMed (Pubitemid 44442916)
11. Chalon S, Delion-Vancassel S, Belzung C, et al. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J Nutr. 1998; 128(12):2512-2519. PubMed
12. Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68(7):1056-1061. doi:10.408/JCP.v68n0712 PubMed
13. Appleton KM, Rogers PJ, Ness AR. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr. 2010;91(3):757-770. doi:10.3945/ajcn.209.28313 PubMed
14. Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr. 2009;28(5):525-542. PubMed
15. Kraguljac NV, Montori VM, Pavuluri M, et al. Efficacy of omega-3 fatty acids in mood disorders - a systematic review and metaanalysis. Psychopharmacol Bull. 2009;42(3):39-54. PubMed
16. Parker G, Gibson NA, Brotchie H, et al. Omega-3 fatty acids and mood disorders. Am J Psychiatry. 2006;163(6):969-978. doi:10.176/api.ajp.163.6.969 PubMed (Pubitemid 44464482)
17. Turnbull T, Cullen-Drill M, Smaldone A. Efficacy of omega-3 fatty acid supplementation on improvement of bipolar symptoms: a systematic review. Arch Psychiatr Nurs. 2008;22(5):305-311. doi:10.1016/j.apnu.208.02.01 PubMed
18. Montgomery P, Richardson AJ. Omega-3 fatty acids for bipolar disorder. Cochrane Database Syst Rev. 2008;(2):CD005169. PubMed
19. Gracious BL, Chirieac MC, Costescu S, et al. Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder. Bipolar Disord. 2010;12(2):142-154. doi:10.1/j.139-5618.2010.079.x PubMed
20. Chiu CC, Huang SY, Chen CC, et al. Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder [letter]. J Clin Psychiatry. 2005;66(12): 1613-1614. doi:10.408/JCP.v6n1219b PubMed
21. Sarris J, Byrne GJ. A systematic review of insomnia and complementary medicine. Sleep Med Rev. 2011;15(2):99-106. doi:10.1016/j.smrv.2010.04.01 PubMed
22. Borenstein M, Hedges L, Higgins J, et al. Introduction to Meta-Analysis. Chichester, UK: Wiley; 2009. doi:10.102/978047074386
23. Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry. 2006;188(1):46-50. doi:10.192/bjp.18.1.46 PubMed (Pubitemid 43021926)
24. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. http://www.cochrane-handbook.org.
25. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558. doi:10.102/sim.186 PubMed (Pubitemid 34746062)
26. Clayton EH, Hanstock TL, Hirneth SJ, et al. Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. Eur J Clin Nutr. 2009;63(8): 1037-1040. doi:10.1038/ejcn.208.81 PubMed
27. Marangell LB, Suppes T, Ketter TA, et al. Omega-3 fatty acids in bipolar disorder: clinical and research considerations. Prostaglandins Leukot Essent Fatty Acids. 2006;75(4-5):315-321. doi:10.1016/j.plefa.206.07.08 PubMed (Pubitemid 44442915)
28. Osher Y, Bersudsky Y, Belmaker RH. Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study. J Clin Psychiatry. 2005;66(6):726-729. doi:10.408/JCP.v6n0608 PubMed (Pubitemid 40942418)
29. Sagduyu K, Dokucu ME, Eddy BA, et al. Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study. Nutr J. 2005;4(1):6. doi:10.186/1475-2891-4-6 PubMed
30. Wozniak J, Biederman J, Mick E, et al. Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial. Eur Neuropsychopharmacol. 2007;17(6-7):440-447. doi:10.1016/j.euroneuro.206.1.06 PubMed (Pubitemid 46497662)
31. Frangou S, Lewis M, Wollard J, et al. Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder. J Psychopharmacol. 2007;21(4):435-439. doi:10.17/0269810606787 PubMed (Pubitemid 47077299)
32. Keck PE Jr, Mintz J, McElroy SL, et al. Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry. 2006;60(9):1020-1022. doi:10.1016/j.biopsych.206.03.056 PubMed (Pubitemid 44739928)
33. Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999;56(5):407-412. doi:10.101/archpsyc.56.5.407 PubMed
34. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133(5):429-435. doi:10.192/bjp.13.5.429 PubMed (Pubitemid 9006756)
35. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
36. Poznanski EO, Cook SC, Carroll BJ, et al. Use of the Children's Depression Rating Scale in an inpatient psychiatric population. J Clin Psychiatry. 1983;44(6):200-203. PubMed
37. Rush AJ, Gullion CM, Basco MR, et al. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med. 1996; 26(3):477-486. doi:10.1017/S0329170358 PubMed (Pubitemid 26142491)
38. Berman NG, Parker RA. Meta-analysis: neither quick nor easy. BMC Med Res Methodol. 2002;2(1):10. doi:10.186/1471-28-2-10 PubMed
39. Jacka FN, Pasco JA, Mykletun A, et al. Association of Western and traditional diets with depression and anxiety in women. Am J Psychiatry. 2010; 167(3):305-311. doi:10.176/api.ajp.209.0906081 PubMed
40. McMillan L, Owen L, Kras M, et al. Behavioural effects of a 10-day Mediterranean diet: results from a pilot study evaluating mood and cognitive performance. Appetite. 2011;56(1):143-147. doi:10.1016/j.apet.2010.1.149 PubMed
41. Freeman MP, Fava M, Lake J, et al. Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force report. J Clin Psychiatry. 2010;71(6):669-681. doi:10.408/JCP.10cs05959blu PubMed
42. Freeman MP, Hibbeln JR, Wisner KL, et al. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand. 2006;113(1):31-35. doi:10.1/j.160-047.205.060.x PubMed (Pubitemid 43339086)